Kevin J Yeaman sold $2.3M of DLB
President and CEO at Dolby Laboratories, Inc.. 34,367 shares at an average of $67.08, traded Dec 9, 2025, filed Dec 11, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.3M at market
- +10Share of holdings soldSold 26% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.9%, 3m -6.5%, 6m -21.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-316180, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +10,615 | $64.60 | $686k | 108,992 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Class A Common Stockindirect: By a trust10b5-1 | +23,752 | $45.50 | $1.1M | 132,744 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -28,168 | $66.99 | $1.9M | 104,576 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Class A Common Stockindirect: By a trust10b5-1 | -6,199 | $67.51 | $418k | 98,377 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -10,615 | $0.00 | $0 | 0 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivativeindirect: By a trust10b5-1 | -23,752 | $0.00 | $0 | 0 | Dec 11, 2025 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 5Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 38Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $77k 1,183 shares | -3% | |
| 22Weak | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $188k 3,000 shares | -4% | |
| 39Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $84k 1,348 shares | -4% | |
| 30Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $22k 357 shares | -1% | |
| 12Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $460k 7,667 shares | -6% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $408k 7,667 shares | -6% | |
| 5Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $426k 7,666 shares | -6% | |
| 55Moderate | Dolby Laboratories, Inc. | Todd Pendleton SVP, Chief Marketing Officer | $648k 11,876 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.